Eur Respir J
-
"Incident tuberculosis in people with HIV across Europe from 2012 to 2022:
incidence rates, risk factors and regional differences in a multicentre cohort
study." C. Kraef, A. Roen, D. Podlekareva, et al. Eur Respir J 2025; 65: 2401904.
Eur Respir J. 2026;67:2451904.
J Infect
- SHAN QQ, Luo M, Zhang Y, Tang D, et al
ANKRD22 as a Novel Diagnostic Biomarker and Immunomodulator in Tuberculosis
Disease: A Multi-Cohort and Clinical Validation Study.
J Infect. 2026 Feb 15:106703. doi: 10.1016/j.jinf.2026.106703.
J Infect Dis
- JUNG E, Bampi JVB, Moura da Silva A, Liu YE, et al
Longitudinal symptom transitions predict incident tuberculosis risk in serial
active case finding.
J Infect Dis. 2026 Feb 21:jiag119. doi: 10.1093.
- MULENGA H, Mendelsohn SC, Fiore-Gartland A, Penn-Nicholson A, et al
Risk factors for immunological sensitization to Mycobacterium tuberculosis and
progression to incident TB disease among HIV-uninfected adults in a high burden
setting.
J Infect Dis. 2026 Feb 18:jiag100. doi: 10.1093.
- HIRANBURANA N, Sophonphan J, Kerr SJ, Ubolyam S, et al
NAT2 polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People
Living with HIV: Insights from a Pharmacogenetic-Pharmacokinetic Cohort Study.
J Infect Dis. 2025 Oct 1:jiaf511. doi: 10.1093.
PLoS Med
- PORTNOY A, Clark RA, Jit M, McQuaid CF, et al
The potential impact of reduced international donor funding on the household
economic burden of tuberculosis in low- and middle-income countries: A modeling
study.
PLoS Med. 2026;23:e1004946.
PLoS One
- BA-IREDIRE E, Avoka JA, Abanga L, Darkie AA, et al
Correction: Prevalence and factors influencing drug-resistant tuberculosis in
four regions of Ghana.
PLoS One. 2026;21:e0343420.
Trop Med Int Health
- RUSWA N, Gunther G, Claassens M
Breakthrough Tuberculosis in a Large Cohort of People Living With HIV on
Preventive Treatment.
Trop Med Int Health. 2026 Feb 19. doi: 10.1111/tmi.70107.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016